CARBOGEN AMCIS Invests Heavily in Switzerland and France

CARBOGEN AMCIS, a Swiss-based pharmaceuticals process development and API and drug products manufacturing company, has announced significant investments to increase manufacturing capacity in Switzerland and France.

The company announced the plans in an Aug. 17, 2020 press release and revealed that it will be opening two new facilities in Switzerland and France over the course of the next four years. The total investment will be more than CHF 100 million (US $110 million).

Within Switzerland, the company will be constructing a new API manufacturing facility at its Hunzenschwil site. The project will start in 2021 and is expected to progress in several phases with completion of the fully operational site in the summer of 2024.

“The facility is designed to provide space for CARBOGEN AMCIS to grow over the next 10 years with the initial phase comprising of 12 new vessels (from 630 liters to 4000 liters) and associated filtration and drying capabilities,” said Stephan Fritschi, vice-president of operations, in the press release. “We have an impressive pipeline, and now our customers can benefit from more diverse offerings.”

Construction of a new facility dedicated to custom development and manufacturing of parenteral drug products is set to begin in January 2021 in France. The new site will be located close to an existing site in Riom and will allow the company to handle complex formulations, including a large range of different types of APIs from biologics to any kind of highly potent compounds.

“After years of growth, it’s exciting to have reached our current production limits and to be able to expand our facilities and grow our capacity, which will match the future market demand,” added Pascal Villemagne, vice president of sales and marketing, in the press release. “Our new facility in Riom will not only enable us to support more customers, but will also give them access to innovative fill/finish technologies.”

Operations at the new French site are expected to commence in the first quarter of 2023.

Source: CARBOGEN AMCIS